Skip to content

Hydralazine: Uses, Side Effects, and How to Take It

Published: July 22, 2026Updated: July 22, 2026

Hydralazine is a prescription blood pressure medicine that relaxes and widens blood vessels. It is used to treat high blood pressure and sometimes heart failure, usually along with other medicines.

Quick summary

Hydralazine can help lower blood pressure, but it may cause dizziness, rapid heartbeat, fluid retention, or a lupus-like immune reaction. Take it exactly as prescribed and ask your doctor or pharmacist about risks and interactions.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 22, 2026Editorial policy

Key facts at a glance

ATC
C02DB02
Generic
Hydralazine
Class
vasodilator
Brands
Apresoline
Availability
rx
Pregnancy
C
Lactation
caution
Half-life (h)
4
Onset (min)
30
Duration (h)
8
Routes
oral, iv
Forms
tablet, injection
Regions
CN, US, EU, JP
Monitoring
blood-pressure, heart-rate

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
25mg four times daily
Maximum
consult physician
Frequency
every 6 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
0.75mg/kg four times daily
Maximum
consult physician
Frequency
every 6 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
10mg three times daily
Maximum
consult physician
Frequency
every 8 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose exceeding 2 grams may cause severe toxicity or death in adults
Chronic overdose: Long-term use above 400mg daily can cause systemic lupus-like syndrome and peripheral neuropathy
Immediate actions
Activated charcoal within 1-2 hours of ingestion if patient is conscious, gastric lavage in severe cases within 1 hour, intravenous fluids, vasopressors for refractory hypotension, continuous cardiac monitoring
Antidote
No specific antidote exists(Supportive care is mainstay of treatment, early intervention improves outcomes)
Poison Control: 1-800-222-1222

Special Populations

6 groups
⚠

pregnancy

general
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

may be used for severe hypertension/preeclampsia when benefits outweigh risks

Monitor

regular blood pressure monitoring and fetal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

general
caution
FDA Category
C
Dose Adjustment

no specific adjustment

Key Recommendations

compatible with breastfeeding per AAP; monitor infant for hypotension

Monitor

monitor infant for lethargy, poor feeding

Use with caution and monitor for adverse effects.

⚠

geriatric

age 65 and older
caution
FDA Category
C
Dose Adjustment

start at 10-25mg daily (lower end of adult range)

Key Recommendations

increased sensitivity to hypotensive effects; start low and titrate slowly

Monitor

frequent blood pressure monitoring, watch for orthostatic hypotension

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children adolescents
caution
FDA Category
C
Dose Adjustment

0.5-2 mg/kg/day divided 2-4 times daily, max 25 mg/day initially

Key Recommendations

used for hypertension in children; limited long-term safety data

Monitor

monitor blood pressure, heart rate, lupus-like symptoms with long-term use

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
C
Dose Adjustment

reduce dose; monitor closely

Key Recommendations

primarily renally excreted; adjust dose in severe impairment (CrCl <30 mL/min)

Monitor

frequent renal function monitoring, blood pressure monitoring

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate to severe
caution
FDA Category
C
Dose Adjustment

reduce dose or avoid in severe impairment

Key Recommendations

extensively metabolized in liver; use with caution in hepatic impairment

Monitor

monitor blood pressure, liver function tests

Use with caution and monitor for adverse effects.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Vasodilator

Hydralazine belongs to the ATC class C02DB01 (Hydrazinophthalazine derivatives)

usageFDA
2023

Primary indications

Value:Hypertension, Heart failure

Therapeutic uses of Hydralazine

mechanismFDA
2023

Mechanism of action

Value:Direct-acting arterial vasodilator

Pharmacological mechanism

prescribingFDA
2023

FDA approval year

Value:1952

Original FDA approval date for Apresoline

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 22, 2026. · Read our editorial policy